Vicentra BV aims to make its Kaleido 2 insulin patch pump and automated insulin delivery system even smaller than its current device, already amongst the smallest, lightest and most precise insulin ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

BeaGL was created by researchers at the University of California Davis and UC Davis Health who were inspired by their own ...

At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Cash call worth about $9 billion based on current value Company says would only use the extra capital if essential Bayer has paid $10 billion on Roundup settlements Share price falls more than 6% ...

The Canadian Diabetes Strategy has four major goals: Develop a health-promotion, disease-prevention strategy for the entire population. Care for and treat First Nations people on-reserve and in Inuit ...

The onset of diabetes is most common in people ages 45 to 64. Type 2 diabetes is the most common form of diabetes. It usually appears after the age of 45 but can occur at any age. The development ...

Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 100 countries.